Effect of interactive ternary mixtures on dispersion characteristics of ipratropium bromide in dry powder inhaler formulations

AAPS PharmSciTech

Volumn 8, Issue 2, 2007, Pages

  Beilmann, Bianca ^a,b   Kubiak, Rene ^a   Grab, Peter ^a   Häusler, Heribert ^a   Langguth, Peter ^b  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Atomic force microscopy; Dry powder inhaler; Interparticle forces; Lactose; Mixing order; Ternary interactive mixture

Indexed keywords

IPRATROPIUM BROMIDE; LACTOSE;

AEROSOL; AIRFLOW; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MIXTURE; DRUG STRUCTURE; DRY POWDER; DYNAMICS; IN VITRO STUDY; PARTICLE SIZE; POWDER INHALER; PREDICTION; QUANTITATIVE ANALYSIS; ADHESION; CHEMISTRY; NEBULIZER; POWDER; SCANNING ELECTRON MICROSCOPY;

ADHESIVENESS; CHEMISTRY, PHARMACEUTICAL; IPRATROPIUM; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS;

EID: 34247866580     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt0802031     Document Type: Article

References (21)

1. Ganderton D. The generation of respirable clouds from coarse powder aggregates. J Biopharm Sci. 1992;3:101-105.
2. Hersey JA. Ordered mixing: a new concept in powder mixing practice. Powder Technol. 1975;11:41-44.
3. Louey MD, Stewart PJ. Particle interactions involved in aerosol dispersion of ternary interactive mixtures. Pharm Res. 2002;19: 1524-1531.
4. Louey MD, Razia S, Stewart PJ. Influence of physico-chemical properties on the in vitro aerosol deposition from interactive mixtures. Int J Pharm. 2003;252:87-98.
5. Flament MP, Leterme P, Gayot A. The influence of carrier roughness, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers. Int J Pharm. 2004;275:201-209.
6. Srichana T, Martin GP, Marriott C. On the relationship between drug and carrier deposition from dry powder inhalers in vitro. Int J Pharm. 1998;167:13-23.
7. Zeng XM, Martin GP, Tee SK, Marriott C. The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro. Int J Pharm. 1998;176:99-110.
8. Zeng XM, Pandal KH, Martin GP. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols. Int J Pharm. 2000;197:41-52.
9. Islam N, Stewart P, Larson I, Hartley P. Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinifoate from lactose-interactive mixtures? Pharm Res. 2004;21:492-499.
10. Steckel H. Inhalation powders - a simple dosage form for pulmonary delivery? Swiss Pharma. 2002;24:15-28.
11. Zeng XM, Martin GP, Marriott C, Pritchard J. The influence of carrier morphology and drug delivery by dry powder inhalers. Int J Pharm. 2000;200:93-106.
12. Podczeck F. Adhesion forces in interactive powder mixtures of a micronized drug and carrier particles of various particle size distributions. J Adhes Sci Technol. 1998;12:1323-1339.
13. Tsukada M, Irie R, Yonemochi Y, et al. Adhesion force measurements of a DPI size pharmaceutical particle by colloid probe atomic force microscopy. Powder Technol. 2004;141:262-269.
14. Zeng XM, Martin GP, Tee SK, Ghoush AA, Marriott C. Effect of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation. Int J Pharm. 1999;182:133-144.
15. Bérard V, Lesniewka E, Andrès C, Pertuy D, Laroche C, Pourcelot Y. Affinity scale between a carrier and a drug in DPI studied by atomic force microscopy. Int J Pharm. 2002;247: 127-137.
16. Begat P, Morton DAV, Staniforth JN, Price R. The cohesive-adhesive balances in dry powder inhaler formulations I: Direct measurements by atomic force microscopy. Pharm Res. 2004;21:1591-1597.
17. Begat P, Morton DAV, Staniforth JN, Price R. The cohesive-adhesive balances in dry powder inhaler formulations II: Influence on fine particle delivery characteristics. Pharm Res. 2004;21:1826-1832.
18. Council of Europe. 2.9.18. Preparation for Inhalation: aerodynamic assessment of fine particle. In: European Pharmacopoeia. 5th ed. Strasbourg, France: Council of Europe; 2006:3103-3315.
19. Dufner J, Jensen J, Schumacher E. Statistik mit SAS Stuttgart, Germany: BG Tuebner Studienbücher; 1992.
20. Little RC, Milliken GA, Stroup WS, Wolfinger RS. SAS System for Mixed Models. Cary, NC: SAS Institute Inc; 1996.
21. Lucas P, Anderson K, Staniforth JN. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers. Pharm Res. 1998;15:562-569